Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
This article has been cited by
1Interpreting febrile neutropenia rates from randomized, controlled trials for consideration of primary prophylaxis in the real world: a systematic review and meta-analysis
J. Truong,E.K. Lee,M.E. Trudeau,K.K.W. Chan
Annals of Oncology.2016;27(4)608
[DOI]
2Patterns of Anthracycline-Based Chemotherapy-Induced Adverse Drug Reactions and Their Impact on Relative Dose Intensity among Women with Breast Cancer in Ethiopia: A Prospective Observational Study
Diriba Alemayehu Gadisa,Mathewos Assefa,Gosaye Mekonen Tefera,Getnet Yimer
Journal of Oncology.2020;2020(4)1
[DOI]
3A Phase IV Clinical Trial of Patients with Solid Tumors Receiving Lenograstim as Primary Prophylaxis for Chemotherapy-Induced Neutropenia, in a Docetaxel-Based Regimen
Samuel J. Fourie,Alicia McMaster,Rashem Mothilal,Keith I. Maart
Journal of Cancer Research.2014;2014(4)1
[DOI]
4Feasibility of two schedules of weekly paclitaxel in HER2-negative early breast cancer in a Brazilian community setting
Iuri A. Santana,Julia Andrade Oliveira,Julianne Maria da Silva Lima,Laura Testa,José Roberto M. Piato,Paulo M. Hoff,Max S. Mano
Breast Cancer.2016;23(2)261
[DOI]
5Retrospective comparison of two consecutive cohorts of adjuvant chemotherapy regimens of cyclophosphamide with either docetaxel or paclitaxel in older patients with early breast cancer
Sofie Joris,Christel Fontaine,Lore Decoster,Leen Vanacker,Denis Schallier,Jacques De Grève
The Breast Journal.2019;25(4)663
[DOI]
6A novel combined method of thin-film evaporation and a supercritical carbon dioxide technique to prepare a fluorescent siRNA-liposome
Lielie Li,Xueqin An
RSC Advances.2016;6(94)92115
[DOI]
7Toxicity profile of Doxorubicin-Cyclophosphamide and Doxorubicin-Cyclophosphamide followed by Paclitaxel regimen and its associated factors among women with breast cancer in Ethiopia: A prospective cohort study
Diriba Alemayehu Gadisa,Mathewos Assefa,Shu-Hua Wang,Getnet Yimer
Journal of Oncology Pharmacy Practice.2020;26(8)1912
[DOI]
8Neutropenia: occurrence and management in women with breast cancer receiving chemotherapy
Talita Garcia do Nascimento,Marceila de Andrade,Rosemeire Aparecida de Oliveira,Ana Maria de Almeida,Thais de Oliveira Gozzo
Revista Latino-Americana de Enfermagem.2014;22(2)301
[DOI]
9Exploring pharmacogenetics of paclitaxel- and docetaxel-induced peripheral neuropathy by evaluating the direct pharmacogenetic-pharmacokinetic and pharmacokinetic-neuropathy relationships
Daniel L Hertz
Expert Opinion on Drug Metabolism & Toxicology.2021;17(2)227
[DOI]
10Decreased body mass index is associated with poor prognosis in patients with multiple myeloma
Sung-Hoon Jung,Deok-Hwan Yang,Jae-Sook Ahn,Seung-Shin Lee,Seo-Yeon Ahn,Yeo-Kyeoung Kim,Hyeoung–Joon Kim,Je-Jung Lee
Annals of Hematology.2014;93(5)835
[DOI]
11Non-viral nanocarriers for siRNA delivery in breast cancer
Jing Zhang,Xiang Li,Leaf Huang
Journal of Controlled Release.2014;190(5)440
[DOI]
12Toxicity profile of taxanes in Tunisian cancer patients: A retrospective study of 90 cases
Sonia Ben Nasr,Aref Zribi,Mouna Ben Hassen,Yosr Doghri,Ichrak Ben Abdallah,Emna Trigui,Sana Fendri,Jihen Ayari,Mehdi Balti,Abderrazek Haddaoui
Bulletin du Cancer.2021;108(3)266
[DOI]
13Routine surveillance for symptomatic toxicities with real-time clinician reporting in Danish breast cancer patients-Organization and design of the first national, cluster randomized trial using the Patient-Reported Outcomes version of Common Terminology C
Helle Pappot,Christina Baeksted,Ann Knoop,Sandra A. Mitchell,Aase Nissen,Christoffer Johansen
The Breast Journal.2019;25(2)269
[DOI]
14Ultrasound-mediated destruction of oxygen and paclitaxel loaded lipid microbubbles for combination therapy in hypoxic ovarian cancer cells
Jiangchuan Sun,Mingyue Yin,Shenyin Zhu,Li Liu,Yi Zhu,Zhigang Wang,Ronald X. Xu,Shufang Chang
Ultrasonics Sonochemistry.2016;28(2)319
[DOI]
15Clinical application of the AUC-guided dosage adjustment of docetaxel-based chemotherapy for patients with solid tumours: a single centre, prospective and randomised control study
Ning Sun,Bo Shen,Jiali Zhu,Xiaomei Zhang,Huayun Zhu,Geyu Liang,Deliang Yang,Jianwei Lu,Yan Zhang
Journal of Translational Medicine.2020;18(1)319
[DOI]
16Vitamin D deficiency increases severity of paclitaxel-induced peripheral neuropathy
Theodore S. Jennaro,Fang Fang,Kelley M. Kidwell,Ellen M. Lavoie Smith,Kiran Vangipuram,Monika L. Burness,Jennifer J. Griggs,Catherine Van Poznak,Daniel F. Hayes,N. Lynn Henry,Daniel L. Hertz
Breast Cancer Research and Treatment.2020;180(3)707
[DOI]
17Taxane acute pain syndrome (TAPS) in patients receiving taxane-based chemotherapy for breast cancer—a systematic review
Ricardo Fernandes,Sasha Mazzarello,Brian Hutton,Risa Shorr,Habeeb Majeed,Mohammed FK Ibrahim,Carmel Jacobs,Michael Ong,Mark Clemons
Supportive Care in Cancer.2016;24(8)3633
[DOI]
18“Chemotherapy-periodized” Exercise to Accommodate for Cyclical Variation in Fatigue
AMY A. KIRKHAM,KELCEY A. BLAND,DAVID S. ZUCKER,JOSHUA BOVARD,TAMARA SHENKIER,DONALD C. MCKENZIE,MARGOT K. DAVIS,KAREN A. GELMON,KRISTIN L. CAMPBELL
Medicine & Science in Sports & Exercise.2020;52(2)278
[DOI]
19An oncolytic herpes simplex virus vector, G47?, synergizes with paclitaxel in the treatment of breast cancer
WEI-GEN ZENG,JUN-JIE LI,PAN HU,LAN LEI,JIA-NI WANG,REN-BIN LIU
Oncology Reports.2013;29(6)2355
[DOI]

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal